vs

Side-by-side financial comparison of Corteva (CTVA) and Vistra Corp. (VST). Click either name above to swap in a different company.

Vistra Corp. is the larger business by last-quarter revenue ($4.8B vs $3.9B, roughly 1.2× Corteva). Vistra Corp. runs the higher net margin — 4.8% vs -14.1%, a 19.0% gap on every dollar of revenue. On growth, Vistra Corp. posted the faster year-over-year revenue change (31.2% vs -1.7%). Corteva produced more free cash flow last quarter ($4.2B vs $596.0M). Over the past eight quarters, Vistra Corp.'s revenue compounded faster (23.3% CAGR vs -6.7%).

Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Corteva sells a large portion of their seeds under the Pioneer Hi-Bred International brand.

Vistra may refer to either of two companies:Vistra, a corporate services company based in Hong Kong Vistra Corp, an energy company based in Texas

CTVA vs VST — Head-to-Head

Bigger by revenue
VST
VST
1.2× larger
VST
$4.8B
$3.9B
CTVA
Growing faster (revenue YoY)
VST
VST
+32.9% gap
VST
31.2%
-1.7%
CTVA
Higher net margin
VST
VST
19.0% more per $
VST
4.8%
-14.1%
CTVA
More free cash flow
CTVA
CTVA
$3.6B more FCF
CTVA
$4.2B
$596.0M
VST
Faster 2-yr revenue CAGR
VST
VST
Annualised
VST
23.3%
-6.7%
CTVA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTVA
CTVA
VST
VST
Revenue
$3.9B
$4.8B
Net Profit
$-552.0M
$233.0M
Gross Margin
42.4%
Operating Margin
-13.6%
9.9%
Net Margin
-14.1%
4.8%
Revenue YoY
-1.7%
31.2%
Net Profit YoY
-1246.3%
-47.2%
EPS (diluted)
$-0.80
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTVA
CTVA
VST
VST
Q4 25
$3.9B
$4.8B
Q3 25
$2.6B
$4.8B
Q2 25
$6.5B
$3.8B
Q1 25
$4.4B
$4.3B
Q4 24
$4.0B
$3.7B
Q3 24
$2.3B
$4.3B
Q2 24
$6.1B
$3.6B
Q1 24
$4.5B
$3.2B
Net Profit
CTVA
CTVA
VST
VST
Q4 25
$-552.0M
$233.0M
Q3 25
$-320.0M
$652.0M
Q2 25
$1.3B
$327.0M
Q1 25
$652.0M
$-268.0M
Q4 24
$-41.0M
$441.0M
Q3 24
$-524.0M
$1.9B
Q2 24
$1.1B
$365.0M
Q1 24
$419.0M
$-35.0M
Gross Margin
CTVA
CTVA
VST
VST
Q4 25
42.4%
Q3 25
37.2%
Q2 25
54.6%
Q1 25
47.0%
Q4 24
37.3%
Q3 24
32.7%
Q2 24
52.3%
Q1 24
43.2%
Operating Margin
CTVA
CTVA
VST
VST
Q4 25
-13.6%
9.9%
Q3 25
-14.1%
21.7%
Q2 25
27.9%
13.7%
Q1 25
17.7%
-2.8%
Q4 24
2.2%
16.4%
Q3 24
-27.2%
59.6%
Q2 24
21.9%
22.5%
Q1 24
10.7%
2.7%
Net Margin
CTVA
CTVA
VST
VST
Q4 25
-14.1%
4.8%
Q3 25
-12.2%
13.6%
Q2 25
20.4%
8.7%
Q1 25
14.8%
-6.3%
Q4 24
-1.0%
12.0%
Q3 24
-22.5%
43.5%
Q2 24
17.2%
10.1%
Q1 24
9.3%
-1.1%
EPS (diluted)
CTVA
CTVA
VST
VST
Q4 25
$-0.80
$0.55
Q3 25
$-0.47
$1.75
Q2 25
$1.92
$0.81
Q1 25
$0.95
$-0.93
Q4 24
$-0.05
$1.09
Q3 24
$-0.76
$5.25
Q2 24
$1.51
$0.90
Q1 24
$0.60
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTVA
CTVA
VST
VST
Cash + ST InvestmentsLiquidity on hand
$4.5B
$785.0M
Total DebtLower is stronger
$1.7B
$15.8B
Stockholders' EquityBook value
$24.1B
$5.1B
Total Assets
$42.8B
$41.5B
Debt / EquityLower = less leverage
0.07×
3.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTVA
CTVA
VST
VST
Q4 25
$4.5B
$785.0M
Q3 25
$2.6B
$602.0M
Q2 25
$2.1B
$458.0M
Q1 25
$2.0B
$561.0M
Q4 24
$3.2B
$1.2B
Q3 24
$2.5B
$905.0M
Q2 24
$2.0B
$1.6B
Q1 24
$1.7B
$1.1B
Total Debt
CTVA
CTVA
VST
VST
Q4 25
$1.7B
$15.8B
Q3 25
$1.7B
$15.8B
Q2 25
$1.7B
$15.5B
Q1 25
$1.8B
$15.4B
Q4 24
$2.0B
$15.4B
Q3 24
$2.0B
$13.9B
Q2 24
$2.5B
$13.9B
Q1 24
$2.5B
$14.7B
Stockholders' Equity
CTVA
CTVA
VST
VST
Q4 25
$24.1B
$5.1B
Q3 25
$25.2B
$5.2B
Q2 25
$25.9B
$4.8B
Q1 25
$24.3B
$4.8B
Q4 24
$23.8B
$5.6B
Q3 24
$24.7B
$5.4B
Q2 24
$25.2B
$5.6B
Q1 24
$24.8B
$5.7B
Total Assets
CTVA
CTVA
VST
VST
Q4 25
$42.8B
$41.5B
Q3 25
$42.2B
$38.0B
Q2 25
$41.8B
$38.1B
Q1 25
$42.1B
$38.2B
Q4 24
$40.8B
$37.8B
Q3 24
$41.9B
$37.9B
Q2 24
$41.5B
$39.1B
Q1 24
$43.6B
$38.2B
Debt / Equity
CTVA
CTVA
VST
VST
Q4 25
0.07×
3.11×
Q3 25
0.07×
3.02×
Q2 25
0.07×
3.22×
Q1 25
0.07×
3.20×
Q4 24
0.08×
2.77×
Q3 24
0.08×
2.56×
Q2 24
0.10×
2.49×
Q1 24
0.10×
2.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTVA
CTVA
VST
VST
Operating Cash FlowLast quarter
$4.4B
$1.4B
Free Cash FlowOCF − Capex
$4.2B
$596.0M
FCF MarginFCF / Revenue
106.2%
12.4%
Capex IntensityCapex / Revenue
5.7%
17.4%
Cash ConversionOCF / Net Profit
6.15×
TTM Free Cash FlowTrailing 4 quarters
$2.8B
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTVA
CTVA
VST
VST
Q4 25
$4.4B
$1.4B
Q3 25
$193.0M
$1.5B
Q2 25
$947.0M
$572.0M
Q1 25
$-2.1B
$599.0M
Q4 24
$4.2B
$1.4B
Q3 24
$130.0M
$1.7B
Q2 24
$451.0M
$1.2B
Q1 24
$-2.6B
$312.0M
Free Cash Flow
CTVA
CTVA
VST
VST
Q4 25
$4.2B
$596.0M
Q3 25
$36.0M
$1.0B
Q2 25
$829.0M
$-118.0M
Q1 25
$-2.2B
$-169.0M
Q4 24
$4.0B
$923.0M
Q3 24
$-24.0M
$1.0B
Q2 24
$337.0M
$698.0M
Q1 24
$-2.8B
$-153.0M
FCF Margin
CTVA
CTVA
VST
VST
Q4 25
106.2%
12.4%
Q3 25
1.4%
21.1%
Q2 25
12.8%
-3.1%
Q1 25
-49.9%
-4.0%
Q4 24
100.4%
25.2%
Q3 24
-1.0%
23.4%
Q2 24
5.5%
19.4%
Q1 24
-61.4%
-4.8%
Capex Intensity
CTVA
CTVA
VST
VST
Q4 25
5.7%
17.4%
Q3 25
6.0%
9.6%
Q2 25
1.8%
18.4%
Q1 25
2.1%
18.1%
Q4 24
4.6%
11.7%
Q3 24
6.6%
15.8%
Q2 24
1.9%
13.8%
Q1 24
3.3%
14.7%
Cash Conversion
CTVA
CTVA
VST
VST
Q4 25
6.15×
Q3 25
2.25×
Q2 25
0.72×
1.75×
Q1 25
-3.23×
Q4 24
3.07×
Q3 24
0.90×
Q2 24
0.43×
3.28×
Q1 24
-6.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTVA
CTVA

Corn$1.4B35%
Herbicides$1.1B27%
Insecticides$488.0M12%
Fungicides$272.0M7%
Biologicals$191.0M5%
Soybean$164.0M4%
Other$160.0M4%
Otheroilseeds$94.0M2%

VST
VST

Retail Energy Charge In ERCOT$2.1B43%
Retail Energy Charge In Northeast Midwest$1.2B24%
East Segment$1.1B24%
Hedging Revenue Realized$170.0M4%
Revenue From Other Wholesale Contracts$116.0M2%
Transferable Production Tax Credit Revenues$78.0M2%
West Segment$77.0M2%
Intersegment Sales$25.0M1%

Related Comparisons